Bioventus Inc. (BVS) Tops Q3 EPS by 1c, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (NASDAQ: BVS) reported Q3 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $142.4 million versus the consensus estimate of $149.51 million.
GUIDANCE:
Bioventus Inc. sees FY 2026 EPS of $0.75-$0.79, versus the consensus of $0.78. Bioventus Inc. sees FY 2026 revenue of $590-595 million, versus the consensus of $604.78 million.
For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
